Table of Content

1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by CAR T-Cell Therapy Revenue

1.5 Market Analysis by Type

1.5.1 Global CAR T-Cell Therapy Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 Allogeneic

1.5.3 Autologous

1.6 Market by Application

1.6.1 Global CAR T-Cell Therapy Market Share by Application: 2022-2027

1.6.2 Hospitals

1.6.3 Cancer Research Centers

1.6.4 Others

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global CAR T-Cell Therapy Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porter’s Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global CAR T-Cell Therapy Market Players Profiles

3.1 Celgene (Juno Therapeutics)

3.1.1 Celgene (Juno Therapeutics) Company Profile

3.1.2 Celgene (Juno Therapeutics) CAR T-Cell Therapy Product Specification

3.1.3 Celgene (Juno Therapeutics) CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 Novartis

3.2.1 Novartis Company Profile

3.2.2 Novartis CAR T-Cell Therapy Product Specification

3.2.3 Novartis CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 Gilead (Kite Pharma)

3.3.1 Gilead (Kite Pharma) Company Profile

3.3.2 Gilead (Kite Pharma) CAR T-Cell Therapy Product Specification

3.3.3 Gilead (Kite Pharma) CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 Pfizer

3.4.1 Pfizer Company Profile

3.4.2 Pfizer CAR T-Cell Therapy Product Specification

3.4.3 Pfizer CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 CARsgen Therapeutics

3.5.1 CARsgen Therapeutics Company Profile

3.5.2 CARsgen Therapeutics CAR T-Cell Therapy Product Specification

3.5.3 CARsgen Therapeutics CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 Autolus Therapeutics

3.6.1 Autolus Therapeutics Company Profile

3.6.2 Autolus Therapeutics CAR T-Cell Therapy Product Specification

3.6.3 Autolus Therapeutics CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 Aurora BioPharma

3.7.1 Aurora BioPharma Company Profile

3.7.2 Aurora BioPharma CAR T-Cell Therapy Product Specification

3.7.3 Aurora BioPharma CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 Sorrento Therapeutics

3.8.1 Sorrento Therapeutics Company Profile

3.8.2 Sorrento Therapeutics CAR T-Cell Therapy Product Specification

3.8.3 Sorrento Therapeutics CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 Mustang Bio

3.9.1 Mustang Bio Company Profile

3.9.2 Mustang Bio CAR T-Cell Therapy Product Specification

3.9.3 Mustang Bio CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 Bluebird Bio

3.10.1 Bluebird Bio Company Profile

3.10.2 Bluebird Bio CAR T-Cell Therapy Product Specification

3.10.3 Bluebird Bio CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.11 Collectis

3.11.1 Collectis Company Profile

3.11.2 Collectis CAR T-Cell Therapy Product Specification

3.11.3 Collectis CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.12 Allogene Therapeutics

3.12.1 Allogene Therapeutics Company Profile

3.12.2 Allogene Therapeutics CAR T-Cell Therapy Product Specification

3.12.3 Allogene Therapeutics CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.13 Celyad

3.13.1 Celyad Company Profile

3.13.2 Celyad CAR T-Cell Therapy Product Specification

3.13.3 Celyad CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global CAR T-Cell Therapy Market Competition by Market Players

4.1 Global CAR T-Cell Therapy Production Capacity Market Share by Market Players (2016-2021)

4.2 Global CAR T-Cell Therapy Revenue Market Share by Market Players (2016-2021)

4.3 Global CAR T-Cell Therapy Average Price by Market Players (2016-2021)

5 Global CAR T-Cell Therapy Production by Regions (2016-2021)

5.1 North America

5.1.1 North America CAR T-Cell Therapy Market Size (2016-2021)

5.1.2 CAR T-Cell Therapy Key Players in North America (2016-2021)

5.1.3 North America CAR T-Cell Therapy Market Size by Type (2016-2021)

5.1.4 North America CAR T-Cell Therapy Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia CAR T-Cell Therapy Market Size (2016-2021)

5.2.2 CAR T-Cell Therapy Key Players in East Asia (2016-2021)

5.2.3 East Asia CAR T-Cell Therapy Market Size by Type (2016-2021)

5.2.4 East Asia CAR T-Cell Therapy Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe CAR T-Cell Therapy Market Size (2016-2021)

5.3.2 CAR T-Cell Therapy Key Players in Europe (2016-2021)

5.3.3 Europe CAR T-Cell Therapy Market Size by Type (2016-2021)

5.3.4 Europe CAR T-Cell Therapy Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia CAR T-Cell Therapy Market Size (2016-2021)

5.4.2 CAR T-Cell Therapy Key Players in South Asia (2016-2021)

5.4.3 South Asia CAR T-Cell Therapy Market Size by Type (2016-2021)

5.4.4 South Asia CAR T-Cell Therapy Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia CAR T-Cell Therapy Market Size (2016-2021)

5.5.2 CAR T-Cell Therapy Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia CAR T-Cell Therapy Market Size by Type (2016-2021)

5.5.4 Southeast Asia CAR T-Cell Therapy Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East CAR T-Cell Therapy Market Size (2016-2021)

5.6.2 CAR T-Cell Therapy Key Players in Middle East (2016-2021)

5.6.3 Middle East CAR T-Cell Therapy Market Size by Type (2016-2021)

5.6.4 Middle East CAR T-Cell Therapy Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa CAR T-Cell Therapy Market Size (2016-2021)

5.7.2 CAR T-Cell Therapy Key Players in Africa (2016-2021)

5.7.3 Africa CAR T-Cell Therapy Market Size by Type (2016-2021)

5.7.4 Africa CAR T-Cell Therapy Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania CAR T-Cell Therapy Market Size (2016-2021)

5.8.2 CAR T-Cell Therapy Key Players in Oceania (2016-2021)

5.8.3 Oceania CAR T-Cell Therapy Market Size by Type (2016-2021)

5.8.4 Oceania CAR T-Cell Therapy Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America CAR T-Cell Therapy Market Size (2016-2021)

5.9.2 CAR T-Cell Therapy Key Players in South America (2016-2021)

5.9.3 South America CAR T-Cell Therapy Market Size by Type (2016-2021)

5.9.4 South America CAR T-Cell Therapy Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World CAR T-Cell Therapy Market Size (2016-2021)

5.10.2 CAR T-Cell Therapy Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World CAR T-Cell Therapy Market Size by Type (2016-2021)

5.10.4 Rest of the World CAR T-Cell Therapy Market Size by Application (2016-2021)

6 Global CAR T-Cell Therapy Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America CAR T-Cell Therapy Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia CAR T-Cell Therapy Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe CAR T-Cell Therapy Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia CAR T-Cell Therapy Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia CAR T-Cell Therapy Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East CAR T-Cell Therapy Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa CAR T-Cell Therapy Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania CAR T-Cell Therapy Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America CAR T-Cell Therapy Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World CAR T-Cell Therapy Consumption by Countries

7 Global CAR T-Cell Therapy Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of CAR T-Cell Therapy (2022-2027)

7.2 Global Forecasted Revenue of CAR T-Cell Therapy (2022-2027)

7.3 Global Forecasted Price of CAR T-Cell Therapy (2022-2027)

7.4 Global Forecasted Production of CAR T-Cell Therapy by Region (2022-2027)

7.4.1 North America CAR T-Cell Therapy Production, Revenue Forecast (2022-2027)

7.4.2 East Asia CAR T-Cell Therapy Production, Revenue Forecast (2022-2027)

7.4.3 Europe CAR T-Cell Therapy Production, Revenue Forecast (2022-2027)

7.4.4 South Asia CAR T-Cell Therapy Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia CAR T-Cell Therapy Production, Revenue Forecast (2022-2027)

7.4.6 Middle East CAR T-Cell Therapy Production, Revenue Forecast (2022-2027)

7.4.7 Africa CAR T-Cell Therapy Production, Revenue Forecast (2022-2027)

7.4.8 Oceania CAR T-Cell Therapy Production, Revenue Forecast (2022-2027)

7.4.9 South America CAR T-Cell Therapy Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World CAR T-Cell Therapy Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of CAR T-Cell Therapy by Application (2022-2027)

8 Global CAR T-Cell Therapy Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of CAR T-Cell Therapy by Country

8.2 East Asia Market Forecasted Consumption of CAR T-Cell Therapy by Country

8.3 Europe Market Forecasted Consumption of CAR T-Cell Therapy by Countriy

8.4 South Asia Forecasted Consumption of CAR T-Cell Therapy by Country

8.5 Southeast Asia Forecasted Consumption of CAR T-Cell Therapy by Country

8.6 Middle East Forecasted Consumption of CAR T-Cell Therapy by Country

8.7 Africa Forecasted Consumption of CAR T-Cell Therapy by Country

8.8 Oceania Forecasted Consumption of CAR T-Cell Therapy by Country

8.9 South America Forecasted Consumption of CAR T-Cell Therapy by Country

8.10 Rest of the world Forecasted Consumption of CAR T-Cell Therapy by Country

9 Global CAR T-Cell Therapy Sales by Type (2016-2027)

9.1 Global CAR T-Cell Therapy Historic Market Size by Type (2016-2021)

9.2 Global CAR T-Cell Therapy Forecasted Market Size by Type (2022-2027)

10 Global CAR T-Cell Therapy Consumption by Application (2016-2027)

10.1 Global CAR T-Cell Therapy Historic Market Size by Application (2016-2021)

10.2 Global CAR T-Cell Therapy Forecasted Market Size by Application (2022-2027)

11 Global CAR T-Cell Therapy Manufacturing Cost Analysis

11.1 CAR T-Cell Therapy Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of CAR T-Cell Therapy

12 Global CAR T-Cell Therapy Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 CAR T-Cell Therapy Distributors List

12.3 CAR T-Cell Therapy Customers

12.4 CAR T-Cell Therapy Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer

List of Figure

Table 1. Research Programs/Design for This Report

Table 2. Key Data Information from Secondary Sources

Table 3. Key Executives Interviewed

Table 4. Key Data Information from Primary Sources

Table 5. Key Players Covered: Ranking by CAR T-Cell Therapy Revenue (US$ Million) 2016-2021

Table 6. Global CAR T-Cell Therapy Market Size by Type (US$ Million): 2022-2027

Table 7. Allogeneic Features

Table 8. Autologous Features

Table 16. Global CAR T-Cell Therapy Market Size by Application (US$ Million): 2022-2027

Table 17. Hospitals Case Studies

Table 18. Cancer Research Centers Case Studies

Table 19. Others Case Studies

Table 26. Overview of the World Economic Outlook Projections

Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 32. Commodity Prices-Metals Price Indices

Table 33. Commodity Prices- Precious Metal Price Indices

Table 34. Commodity Prices- Agricultural Raw Material Price Indices

Table 35. Commodity Prices- Food and Beverage Price Indices

Table 36. Commodity Prices- Fertilizer Price Indices

Table 37. Commodity Prices- Energy Price Indices

Table 38. G20+: Economic Policy Responses to COVID-19

Table 39. Covid-19 Impact: Global Major Government Policy

Table 40. CAR T-Cell Therapy Report Years Considered

Table 41. Market Top Trends

Table 42. Key Drivers: Impact Analysis

Table 43. Key Challenges

Table 44. Porter's Five Forces Analysis

Table 45. CAR T-Cell Therapy Market Growth Strategy

Table 46. CAR T-Cell Therapy SWOT Analysis

Table 47. Celgene (Juno Therapeutics) CAR T-Cell Therapy Product Specification

Table 48. Celgene (Juno Therapeutics) CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 49. Novartis CAR T-Cell Therapy Product Specification

Table 50. Novartis CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 51. Gilead (Kite Pharma) CAR T-Cell Therapy Product Specification

Table 52. Gilead (Kite Pharma) CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 53. Pfizer CAR T-Cell Therapy Product Specification

Table 54. Table Pfizer CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 55. CARsgen Therapeutics CAR T-Cell Therapy Product Specification

Table 56. CARsgen Therapeutics CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 57. Autolus Therapeutics CAR T-Cell Therapy Product Specification

Table 58. Autolus Therapeutics CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 59. Aurora BioPharma CAR T-Cell Therapy Product Specification

Table 60. Aurora BioPharma CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 61. Sorrento Therapeutics CAR T-Cell Therapy Product Specification

Table 62. Sorrento Therapeutics CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 63. Mustang Bio CAR T-Cell Therapy Product Specification

Table 64. Mustang Bio CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 65. Bluebird Bio CAR T-Cell Therapy Product Specification

Table 66. Bluebird Bio CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 67. Collectis CAR T-Cell Therapy Product Specification

Table 68. Collectis CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 69. Allogene Therapeutics CAR T-Cell Therapy Product Specification

Table 70. Allogene Therapeutics CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 71. Celyad CAR T-Cell Therapy Product Specification

Table 72. Celyad CAR T-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 147. Global CAR T-Cell Therapy Production Capacity by Market Players

Table 148. Global CAR T-Cell Therapy Production by Market Players (2016-2021)

Table 149. Global CAR T-Cell Therapy Production Market Share by Market Players (2016-2021)

Table 150. Global CAR T-Cell Therapy Revenue by Market Players (2016-2021)

Table 151. Global CAR T-Cell Therapy Revenue Share by Market Players (2016-2021)

Table 152. Global Market CAR T-Cell Therapy Average Price of Key Market Players (2016-2021)

Table 153. North America Key Players CAR T-Cell Therapy Revenue (2016-2021) (US$ Million)

Table 154. North America Key Players CAR T-Cell Therapy Market Share (2016-2021)

Table 155. North America CAR T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)

Table 156. North America CAR T-Cell Therapy Market Share by Type (2016-2021)

Table 157. North America CAR T-Cell Therapy Market Size by Application (2016-2021) (US$ Million)

Table 158. North America CAR T-Cell Therapy Market Share by Application (2016-2021)

Table 159. East Asia CAR T-Cell Therapy Market Size YoY Growth (2016-2021) (US$ Million)

Table 160. East Asia Key Players CAR T-Cell Therapy Revenue (2016-2021) (US$ Million)

Table 161. East Asia Key Players CAR T-Cell Therapy Market Share (2016-2021)

Table 162. East Asia CAR T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)

Table 163. East Asia CAR T-Cell Therapy Market Share by Type (2016-2021)

Table 164. East Asia CAR T-Cell Therapy Market Size by Application (2016-2021) (US$ Million)

Table 165. East Asia CAR T-Cell Therapy Market Share by Application (2016-2021)

Table 166. Europe CAR T-Cell Therapy Market Size YoY Growth (2016-2021) (US$ Million)

Table 167. Europe Key Players CAR T-Cell Therapy Revenue (2016-2021) (US$ Million)

Table 168. Europe Key Players CAR T-Cell Therapy Market Share (2016-2021)

Table 169. Europe CAR T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)

Table 170. Europe CAR T-Cell Therapy Market Share by Type (2016-2021)

Table 171. Europe CAR T-Cell Therapy Market Size by Application (2016-2021) (US$ Million)

Table 172. Europe CAR T-Cell Therapy Market Share by Application (2016-2021)

Table 173. South Asia CAR T-Cell Therapy Market Size YoY Growth (2016-2021) (US$ Million)

Table 174. South Asia Key Players CAR T-Cell Therapy Revenue (2016-2021) (US$ Million)

Table 175. South Asia Key Players CAR T-Cell Therapy Market Share (2016-2021)

Table 176. South Asia CAR T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)

Table 177. South Asia CAR T-Cell Therapy Market Share by Type (2016-2021)

Table 178. South Asia CAR T-Cell Therapy Market Size by Application (2016-2021) (US$ Million)

Table 179. South Asia CAR T-Cell Therapy Market Share by Application (2016-2021)

Table 180. Southeast Asia CAR T-Cell Therapy Market Size YoY Growth (2016-2021) (US$ Million)

Table 181. Southeast Asia Key Players CAR T-Cell Therapy Revenue (2016-2021) (US$ Million)

Table 182. Southeast Asia Key Players CAR T-Cell Therapy Market Share (2016-2021)

Table 183. Southeast Asia CAR T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)

Table 184. Southeast Asia CAR T-Cell Therapy Market Share by Type (2016-2021)

Table 185. Southeast Asia CAR T-Cell Therapy Market Size by Application (2016-2021) (US$ Million)

Table 186. Southeast Asia CAR T-Cell Therapy Market Share by Application (2016-2021)

Table 187. Middle East CAR T-Cell Therapy Market Size YoY Growth (2016-2021) (US$ Million)

Table 188. Middle East Key Players CAR T-Cell Therapy Revenue (2016-2021) (US$ Million)

Table 189. Middle East Key Players CAR T-Cell Therapy Market Share (2016-2021)

Table 190. Middle East CAR T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)

Table 191. Middle East CAR T-Cell Therapy Market Share by Type (2016-2021)

Table 192. Middle East CAR T-Cell Therapy Market Size by Application (2016-2021) (US$ Million)

Table 193. Middle East CAR T-Cell Therapy Market Share by Application (2016-2021)

Table 194. Africa CAR T-Cell Therapy Market Size YoY Growth (2016-2021) (US$ Million)

Table 195. Africa Key Players CAR T-Cell Therapy Revenue (2016-2021) (US$ Million)

Table 196. Africa Key Players CAR T-Cell Therapy Market Share (2016-2021)

Table 197. Africa CAR T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)

Table 198. Africa CAR T-Cell Therapy Market Share by Type (2016-2021)

Table 199. Africa CAR T-Cell Therapy Market Size by Application (2016-2021) (US$ Million)

Table 200. Africa CAR T-Cell Therapy Market Share by Application (2016-2021)

Table 201. Oceania CAR T-Cell Therapy Market Size YoY Growth (2016-2021) (US$ Million)

Table 202. Oceania Key Players CAR T-Cell Therapy Revenue (2016-2021) (US$ Million)

Table 203. Oceania Key Players CAR T-Cell Therapy Market Share (2016-2021)

Table 204. Oceania CAR T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)

Table 205. Oceania CAR T-Cell Therapy Market Share by Type (2016-2021)

Table 206. Oceania CAR T-Cell Therapy Market Size by Application (2016-2021) (US$ Million)

Table 207. Oceania CAR T-Cell Therapy Market Share by Application (2016-2021)

Table 208. South America CAR T-Cell Therapy Market Size YoY Growth (2016-2021) (US$ Million)

Table 209. South America Key Players CAR T-Cell Therapy Revenue (2016-2021) (US$ Million)

Table 210. South America Key Players CAR T-Cell Therapy Market Share (2016-2021)

Table 211. South America CAR T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)

Table 212. South America CAR T-Cell Therapy Market Share by Type (2016-2021)

Table 213. South America CAR T-Cell Therapy Market Size by Application (2016-2021) (US$ Million)

Table 214. South America CAR T-Cell Therapy Market Share by Application (2016-2021)

Table 215. Rest of the World CAR T-Cell Therapy Market Size YoY Growth (2016-2021) (US$ Million)

Table 216. Rest of the World Key Players CAR T-Cell Therapy Revenue (2016-2021) (US$ Million)

Table 217. Rest of the World Key Players CAR T-Cell Therapy Market Share (2016-2021)

Table 218. Rest of the World CAR T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)

Table 219. Rest of the World CAR T-Cell Therapy Market Share by Type (2016-2021)

Table 220. Rest of the World CAR T-Cell Therapy Market Size by Application (2016-2021) (US$ Million)

Table 221. Rest of the World CAR T-Cell Therapy Market Share by Application (2016-2021)

Table 222. North America CAR T-Cell Therapy Consumption by Countries (2016-2021)

Table 223. East Asia CAR T-Cell Therapy Consumption by Countries (2016-2021)

Table 224. Europe CAR T-Cell Therapy Consumption by Region (2016-2021)

Table 225. South Asia CAR T-Cell Therapy Consumption by Countries (2016-2021)

Table 226. Southeast Asia CAR T-Cell Therapy Consumption by Countries (2016-2021)

Table 227. Middle East CAR T-Cell Therapy Consumption by Countries (2016-2021)

Table 228. Africa CAR T-Cell Therapy Consumption by Countries (2016-2021)

Table 229. Oceania CAR T-Cell Therapy Consumption by Countries (2016-2021)

Table 230. South America CAR T-Cell Therapy Consumption by Countries (2016-2021)

Table 231. Rest of the World CAR T-Cell Therapy Consumption by Countries (2016-2021)

Table 232. Global CAR T-Cell Therapy Production Forecast by Region (2022-2027)

Table 233. Global CAR T-Cell Therapy Sales Volume Forecast by Type (2022-2027)

Table 234. Global CAR T-Cell Therapy Sales Volume Market Share Forecast by Type (2022-2027)

Table 235. Global CAR T-Cell Therapy Sales Revenue Forecast by Type (2022-2027)

Table 236. Global CAR T-Cell Therapy Sales Revenue Market Share Forecast by Type (2022-2027)

Table 237. Global CAR T-Cell Therapy Sales Price Forecast by Type (2022-2027)

Table 238. Global CAR T-Cell Therapy Consumption Volume Forecast by Application (2022-2027)

Table 239. Global CAR T-Cell Therapy Consumption Value Forecast by Application (2022-2027)

Table 240. North America CAR T-Cell Therapy Consumption Forecast 2022-2027 by Country

Table 241. East Asia CAR T-Cell Therapy Consumption Forecast 2022-2027 by Country

Table 242. Europe CAR T-Cell Therapy Consumption Forecast 2022-2027 by Country

Table 243. South Asia CAR T-Cell Therapy Consumption Forecast 2022-2027 by Country

Table 244. Southeast Asia CAR T-Cell Therapy Consumption Forecast 2022-2027 by Country

Table 245. Middle East CAR T-Cell Therapy Consumption Forecast 2022-2027 by Country

Table 246. Africa CAR T-Cell Therapy Consumption Forecast 2022-2027 by Country

Table 247. Oceania CAR T-Cell Therapy Consumption Forecast 2022-2027 by Country

Table 248. South America CAR T-Cell Therapy Consumption Forecast 2022-2027 by Country

Table 249. Rest of the world CAR T-Cell Therapy Consumption Forecast 2022-2027 by Country

Table 250. Global CAR T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)

Table 251. Global CAR T-Cell Therapy Revenue Market Share by Type (2016-2021)

Table 252. Global CAR T-Cell Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 253. Global CAR T-Cell Therapy Revenue Market Share by Type (2022-2027)

Table 254. Global CAR T-Cell Therapy Market Size by Application (2016-2021) (US$ Million)

Table 255. Global CAR T-Cell Therapy Revenue Market Share by Application (2016-2021)

Table 256. Global CAR T-Cell Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 257. Global CAR T-Cell Therapy Revenue Market Share by Application (2022-2027)

Table 258. CAR T-Cell Therapy Distributors List

Table 259. CAR T-Cell Therapy Customers List





Figure 1. Product Figure

Figure 2. Global CAR T-Cell Therapy Market Share by Type: 2021 VS 2027

Figure 3. Global CAR T-Cell Therapy Market Share by Application: 2021 VS 2027

Figure 4. North America CAR T-Cell Therapy Market Size YoY Growth (2016-2021) (US$ Million)

Figure 5. North America CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 6. North America CAR T-Cell Therapy Consumption Market Share by Countries in 2021

Figure 7. United States CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 8. Canada CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 9. Mexico CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 10. East Asia CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 11. East Asia CAR T-Cell Therapy Consumption Market Share by Countries in 2021

Figure 12. China CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 13. Japan CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 14. South Korea CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 15. Europe CAR T-Cell Therapy Consumption and Growth Rate

Figure 16. Europe CAR T-Cell Therapy Consumption Market Share by Region in 2021

Figure 17. Germany CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 18. United Kingdom CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 19. France CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 20. Italy CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 21. Russia CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 22. Spain CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 23. Netherlands CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 24. Switzerland CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 25. Poland CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 26. South Asia CAR T-Cell Therapy Consumption and Growth Rate

Figure 27. South Asia CAR T-Cell Therapy Consumption Market Share by Countries in 2021

Figure 28. India CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 29. Southeast Asia CAR T-Cell Therapy Consumption and Growth Rate

Figure 30. Southeast Asia CAR T-Cell Therapy Consumption Market Share by Countries in 2021

Figure 31. Indonesia CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 32. Thailand CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 33. Singapore CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 34. Malaysia CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 35. Philippines CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 36. Middle East CAR T-Cell Therapy Consumption and Growth Rate

Figure 37. Middle East CAR T-Cell Therapy Consumption Market Share by Countries in 2021

Figure 38. Turkey CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 39. Saudi Arabia CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 40. Iran CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 41. United Arab Emirates CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 42. Africa CAR T-Cell Therapy Consumption and Growth Rate

Figure 43. Africa CAR T-Cell Therapy Consumption Market Share by Countries in 2021

Figure 44. Nigeria CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 45. South Africa CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 46. Oceania CAR T-Cell Therapy Consumption and Growth Rate

Figure 47. Oceania CAR T-Cell Therapy Consumption Market Share by Countries in 2021

Figure 48. Australia CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 49. South America CAR T-Cell Therapy Consumption and Growth Rate

Figure 50. South America CAR T-Cell Therapy Consumption Market Share by Countries in 2021

Figure 51. Brazil CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 52. Argentina CAR T-Cell Therapy Consumption and Growth Rate (2016-2021)

Figure 53. Rest of the World CAR T-Cell Therapy Consumption and Growth Rate

Figure 54. Rest of the World CAR T-Cell Therapy Consumption Market Share by Countries in 2021

Figure 55. Global CAR T-Cell Therapy Production Capacity Growth Rate Forecast (2022-2027)

Figure 56. Global CAR T-Cell Therapy Revenue Growth Rate Forecast (2022-2027)

Figure 57. Global CAR T-Cell Therapy Price and Trend Forecast (2022-2027)

Figure 58. North America CAR T-Cell Therapy Production Growth Rate Forecast (2022-2027)

Figure 59. North America CAR T-Cell Therapy Revenue Growth Rate Forecast (2022-2027)

Figure 60. East Asia CAR T-Cell Therapy Production Growth Rate Forecast (2022-2027)

Figure 61. East Asia CAR T-Cell Therapy Revenue Growth Rate Forecast (2022-2027)

Figure 62. Europe CAR T-Cell Therapy Production Growth Rate Forecast (2022-2027)

Figure 63. Europe CAR T-Cell Therapy Revenue Growth Rate Forecast (2022-2027)

Figure 64. South Asia CAR T-Cell Therapy Production Growth Rate Forecast (2022-2027)

Figure 65. South Asia CAR T-Cell Therapy Revenue Growth Rate Forecast (2022-2027)

Figure 66. Southeast Asia CAR T-Cell Therapy Production Growth Rate Forecast (2022-2027)

Figure 67. Southeast Asia CAR T-Cell Therapy Revenue Growth Rate Forecast (2022-2027)

Figure 68. Middle East CAR T-Cell Therapy Production Growth Rate Forecast (2022-2027)

Figure 69. Middle East CAR T-Cell Therapy Revenue Growth Rate Forecast (2022-2027)

Figure 70. Africa CAR T-Cell Therapy Production Growth Rate Forecast (2022-2027)

Figure 71. Africa CAR T-Cell Therapy Revenue Growth Rate Forecast (2022-2027)

Figure 72. Oceania CAR T-Cell Therapy Production Growth Rate Forecast (2022-2027)

Figure 73. Oceania CAR T-Cell Therapy Revenue Growth Rate Forecast (2022-2027)

Figure 74. South America CAR T-Cell Therapy Production Growth Rate Forecast (2022-2027)

Figure 75. South America CAR T-Cell Therapy Revenue Growth Rate Forecast (2022-2027)

Figure 76. Rest of the World CAR T-Cell Therapy Production Growth Rate Forecast (2022-2027)

Figure 77. Rest of the World CAR T-Cell Therapy Revenue Growth Rate Forecast (2022-2027)

Figure 78. North America CAR T-Cell Therapy Consumption Forecast 2022-2027

Figure 79. East Asia CAR T-Cell Therapy Consumption Forecast 2022-2027

Figure 80. Europe CAR T-Cell Therapy Consumption Forecast 2022-2027

Figure 81. South Asia CAR T-Cell Therapy Consumption Forecast 2022-2027

Figure 82. Southeast Asia CAR T-Cell Therapy Consumption Forecast 2022-2027

Figure 83. Middle East CAR T-Cell Therapy Consumption Forecast 2022-2027

Figure 84. Africa CAR T-Cell Therapy Consumption Forecast 2022-2027

Figure 85. Oceania CAR T-Cell Therapy Consumption Forecast 2022-2027

Figure 86. South America CAR T-Cell Therapy Consumption Forecast 2022-2027

Figure 87. Rest of the world CAR T-Cell Therapy Consumption Forecast 2022-2027

Figure 88. Manufacturing Cost Structure of CAR T-Cell Therapy

Figure 89. Manufacturing Process Analysis of CAR T-Cell Therapy

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. CAR T-Cell Therapy Supply Chain Analysis